Heilbron, Karl
Noyce, Alastair J.
Fontanillas, Pierre
Alipanahi, Babak http://orcid.org/0000-0001-8216-7178
Nalls, Mike A.
Agee, M.
Auton, A.
Bell, R. K.
Bryc, K.
Elson, S. L.
Furlotte, N. A.
Hinds, D. A.
McCreight, J. C.
Huber, K. E.
Kleinman, A.
Litterman, N. K.
McIntyre, M. H.
Mountain, J. L.
Noblin, E. S.
Northover, C. A. M.
Pitts, S. J.
Sathirapongsasuti, J. F.
Sazonova, O. V.
Shelton, J. F.
Shringarpure, S.
Tian, C.
Tung, J. Y.
Vacic, V.
Wilson, C. H.
Cannon, Paul
,
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (MJFF12737, MJFF12737, MJFF12737)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (Z01-AG000949-02)
Article History
Received: 29 October 2018
Accepted: 4 March 2019
First Online: 27 March 2019
Competing interests
: Drs. Heilbron, Fontanillas, Alipanahi, Cannon, and members of the 23andMe Research Team are employees of and have stock, stock options, or both, in 23andMe. Dr. Nalls is supported by a consulting contract between Data Tecnica International and the National Institute on Aging (project number: Z01-AG000949-02). The remaining authors declare no competing interests.